166 related articles for article (PubMed ID: 38436491)
1. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
Am J Hypertens; 2024 May; 37(6):438-446. PubMed ID: 38436491
[TBL] [Abstract][Full Text] [Related]
2. Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
Bakris G; Lin PP; Xu C; Chen C; Ashton V; Singhal M
J Clin Hypertens (Greenwich); 2024 May; 26(5):500-513. PubMed ID: 38523465
[TBL] [Abstract][Full Text] [Related]
3. Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus.
Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
J Clin Hypertens (Greenwich); 2023 Aug; 25(8):737-747. PubMed ID: 37461262
[TBL] [Abstract][Full Text] [Related]
4. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.
Mwasongwe SE; Tanner RM; Poudel B; Pugliese DN; Young BA; Abdalla M; Musani SK; Gutiérrez OM; Correa A; Shimbo D; Muntner P
Clin J Am Soc Nephrol; 2020 Apr; 15(4):501-510. PubMed ID: 32217635
[TBL] [Abstract][Full Text] [Related]
6. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
Tanner RM; Shimbo D; Irvin MR; Spruill TM; Bromfield SG; Seals SR; Young BA; Muntner P
J Clin Hypertens (Greenwich); 2017 Nov; 19(11):1117-1124. PubMed ID: 28921875
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
[TBL] [Abstract][Full Text] [Related]
10. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
[TBL] [Abstract][Full Text] [Related]
13. Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
Yan Z; Wang Y; Li S; Wang J; Zhang L; Tan H; Li S; Yang L; Pei H; Zhang L; Wang Y; Duan J; Jiao S; Zhao M; Fu S;
Am J Hypertens; 2018 Mar; 31(4):486-494. PubMed ID: 29304216
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
[TBL] [Abstract][Full Text] [Related]
15. Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.
Hwang AY; Dave CV; Smith SM
Am J Hypertens; 2018 Nov; 31(12):1324-1331. PubMed ID: 30052747
[TBL] [Abstract][Full Text] [Related]
16. Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes.
Viazzi F; Greco E; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
Kidney Blood Press Res; 2018; 43(2):422-438. PubMed ID: 29698970
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.
Zhang J; Healy HG; Venuthurupalli SK; Tan KS; Wang Z; Cameron A; Hoy WE
BMC Nephrol; 2019 Sep; 20(1):348. PubMed ID: 31484506
[TBL] [Abstract][Full Text] [Related]
19. Blood Pressure Control During Chronic Kidney Disease Progression.
Lee S; Oh HJ; Lee EK; Lee O; Ha E; Kim SJ; Kang DH; Choi KB; Ryu DR
Am J Hypertens; 2017 Jun; 30(6):610-616. PubMed ID: 28338771
[TBL] [Abstract][Full Text] [Related]
20. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; McClellan W; Warnock DG; Muntner P
Am J Kidney Dis; 2014 May; 63(5):781-8. PubMed ID: 24388119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
